As of March 17, 2024, Toumai^® Laparoscopic Surgical Robot (referred to as Toumai^® Robot) has surpassed 2,000 human clinical surgeries in urology, general surgery, thoracic surgery, gynecology, and pediatric surgery in nearly 90 hospitals both domestically and internationally!

Among the 2,000 human clinical surgeries, the Toumai^® Robot has successfully completed over 1,600 Level 4 high-difficulty surgeries, covering nearly 300 applicable procedures and achieving nearly 50 "domestic firsts"; it has conducted over 120 exploratory 5G remote surgeries with a 100% success rate, creating nearly 20 world-first or first-time records. The furthest distance for master-slave control reached nearly 13,000 kilometers, assisting experts domestically and internationally in conducting scientific research. The overseas market has achieved a breakthrough in human clinical surgeries with domestically produced laparoscopic surgical robots, promoting the global development of minimally invasive surgical techniques with Chinese intelligent surgical solutions. This is a true portrayal of Toumai^® leading new breakthroughs in the domestic surgical robot industry in terms of multi-department clinical applications, remote technology innovation, and international market expansion, MicroPort^® MedBot™ injecting abundant momentum into the development of the domestic surgical robot industry through digital empowerment, cutting-edge technology, and core technology.

Leading comprehensive applications

Making surgical treatments precise, efficient, and low-risk

Robot-assisted surgery has become one of the most prominent emerging technologies in modern medicine. Since obtaining NMPA approval for listing in January 2022 and receiving multi-department indications in September 2023, the Toumai^® Robot has opened up new horizons and provided new solutions for the development of minimally invasive surgery in urology, general surgery, thoracic surgery, gynecology, and pediatric surgery in China.

▲ Conquering the "Mount Everest" of general surgery

Toumai^® assists in the first domestic case of pancreaticoduodenectomy

Highlights:

Domestic breakthrough! Toumai^® four-arm laparoscopic surgical robot successfully completes 300 clinical verification surgeries

Milestone | Domestic MicroPort^® MedBot™ Toumai^® Laparoscopic Surgical Robot surpasses 500 surgeries

New breakthrough, new journey! Domestic Toumai^® Robot accumulates over 1,000 surgeries!

Toumai^® surpasses 1,500 clinical surgeries, marking a breakthrough for laparoscopic surgical robots

▲ Finer resections, more precise reconstructions

Toumai^® assists in the first domestic case of buccal mucosa patch ureteral repair

The strong technical capabilities and reliable performance of the Toumai^® Robot have been widely recognized and welcomed by many doctors, enabling experts to bravely explore new procedures with the assistance of Toumai^® and achieve one "domestic first" after another. Currently, the Toumai^® Robot covers nearly 300 applicable procedures in clinical applications, with nearly 50 "domestic firsts," ensuring precise, safe, and efficient minimally invasive surgical treatments.

Pioneering forward-looking explorations

Toumai^® leads global remote surgery into the "global village" era

Remote surgery is a powerful extension and complement to traditional surgery, greatly expanding the time and space for surgical procedures. With the development and maturity of domestic robotic surgery systems and communication technologies, China has made significant progress in the field of remote surgery. In early January this year, the Toumai^® Robot completed the first 100 cases of 5G remote surgery globally. To date, the Toumai^® Robot has assisted domestic and international experts in conducting over 120 exploratory remote surgeries, achieving full coverage of multiple departments and procedures in various terrains and environments, with a 100% success rate, fully validating its technological reliability, stable performance, and treatment safety.

▲ Toumai^® assists in the world's first "global" ultra-long-distance simulated surgery verification

From late January to early February, the Minimally Invasive^® Robot brought remote practice to the global stage. The Toumai^® Robot successfully assisted in the world's first "global" ultra-long-distance simulated surgery verification and animal experiments, breaking the record for the furthest distance for master-slave control three times. This marks the Minimally Invasive^® Robot leading a new breakthrough in Chinese remote surgery, overcoming the challenges of routine global remote surgery applications, and providing better solutions for global medical surgeries. The Toumai^® Robot has achieved 20 global firsts (or first instances) in the field of remote surgery, showcasing the innovative strength, technological advantages, and leading position of domestic laparoscopic surgical robots in the field of remote surgery.

▲ Toumai^® assists in the world's first remote radical distal gastrectomy for cancer

Recently, an academic paper titled " Pioneering case: Robot-assisted remote radical distal gastrectomy for gastric cancer based on 5G communication technology" was published in the international journal "Intelligent Surgery." The paper, completed by Professor Zhao Qun's team from the Fourth Hospital of Hebei Medical University, verified the feasibility and safety of using the Toumai^® Robot to assist in remote surgeries for radical distal gastrectomy in gastric cancer with detailed surgical data and rigorous scientific conclusions, attracting significant attention in the international field of minimally invasive surgery.

Highlights:

First to complete 100 cases of 5G remote surgery globally, Toumai^® 5G opens a new chapter in global remote surgery development

Crossing 7,000 kilometers, Toumai^® completes the world's first transcontinental 5G ultra-long-distance simulated surgery verification

World's first "global" remote surgery operation verification, first intercontinental 5G remote animal experiment, Toumai^® propels remote surgery into a new era

Intelligent Surgery paper recommendation | 5G remote robotic surgery, ushering in a new era of gastric cancer treatment

▲ Toumai^® assists in the world's first pediatric surgery 5G ultra-long-distance surgery

The Toumai^® Robot conducts forward-looking explorations with technical innovations, continuously maturing remote surgical technology, accelerating the application of remote surgery, and leading global remote surgery into the "global village" era. In the future, the "surgical knife" of top surgeons will be able to reach various parts of the world and even outer space, providing increasingly high-quality and effective surgical treatments for patients.

From 0 to 1, overseas human clinical procedures become standardized

Toumai^® initiates a new era of internationalization for domestic laparoscopic surgical robot

Recently, the Toumai^® Robot successfully assisted in the first overseas human clinical surgery. Following orthopedic surgical robot and vascular interventional surgical robot, this breakthrough in the field of laparoscopic surgical robot marks a new era of international clinical applications for domestic surgical robots, opening a new chapter for in-depth cooperation between domestic surgical robot enterprises and overseas clinical experts.

▲ Toumai^® assists in the first overseas human clinical surgery with a domestic laparoscopic surgical robot

Highlights:

First overseas sale of Toumai^® Robot, marking the official globalization of domestic laparoscopic surgical robot industry!

Domestic laparoscopic surgical robot completes the first human surgery in overseas markets

Seizing this opportunity, the MicroPort^® MedBot™ will strengthen cooperation with clinical experts from various countries, engage in in-depth communication and exchanges, listen to the personalized market needs of various countries, and enhance customer service capabilities together. Based on this foundation, it will promote a deeper understanding of new Chinese robotic surgical products, technologies, and solutions in the international market, continuously introducing more high-quality and innovative high-end products to domestic and international markets.

Dr. He Chao, President of the MicroPort^® MedBot™, stated: The Toumai^® Robot has reached new heights in surgical volume, achieving "pioneering" breakthroughs in multiple fields, leading the development of the Chinese surgical robot industry, setting a typical paradigm, and driving the entire industry chain to thrive. The successful commercialization of the Toumai^® Robot in both domestic and international markets fully demonstrates its outstanding clinical value, unique technological innovation, excellent product quality, and comprehensive training services, meeting market demands entirely. Leveraging our research and development, production, and commercialization advantages in the field of surgical robots, we will continue to optimize innovative products to meet the needs of different hospitals and doctors, empower regional medical challenges, benefit more patients globally, and fulfill the mission of " Make Surgery Easier, Safer and Less Invasive."